CAS: 2289690-31-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MYCi361 REF: TM-T12132CAS: 2289690-31-7 | 99.52% | 116,00 €~1.359,00 € | Mar 04 Mar 25 |
 | 6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol REF: IN-DA01KKRSCAS: 2289690-31-7 | 98% | A consultar | Mar 04 Mar 25 |
 | MYCi361 REF: 3D-PRD69031CAS: 2289690-31-7 | Min. 95% | A consultar | Mar 15 Abr 25 |
MYCi361
CAS:2289690-31-7
MYCi361 (NUCC-0196361) is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM).
Fórmula:
C26H16ClF9N2O2
Pureza:
99.52%
Forma y color:
Solid
Peso molecular:
594.86
Ref: TM-T12132
| 1mg | 116,00 € | ||
| 5mg | 273,00 € | ||
| 10mg | 434,00 € | ||
| 25mg | 715,00 € | ||
| 50mg | 1.008,00 € | ||
| 100mg | 1.359,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol
CAS:2289690-31-7
Fórmula:
C26H16ClF9N2O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
594.8561
Ref: IN-DA01KKRS
| 5mg | 59,00 € | ||
| 25mg | 133,00 € | ||
| 100mg | 322,00 € | ||
| 200mg | 526,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
MYCi361
CAS:2289690-31-7
MYCi361 is an antibody-drug conjugate that targets the histone deacetylase. MYCi361 has been shown to …
Fórmula:
C26H16ClF9N2O2
Pureza:
Min. 95%
Peso molecular:
594.9 g/mol
Ref: 3D-PRD69031
| 10mg | 713,00 € | ||
| 25mg | 1.199,00 € | ||
| 50mg | 1.918,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025
